Skip to main content

Table 1 Demographics of the study population

From: Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study

 ControlsHealthy nonagenariansCI nonagenarians
OCT analyses N1725223
SIVA analyses N1735024
Age (years)70.4 (±7.5)92.4 (±1.9)91.9 (±2.9)
Sex, female N (%)105 (57.4%)30 (52.6%)20 (74.1%)
BCVA (LogMAR)0.02 (±0.10)0.14 (±0.21)0.13 (±0.22)
Intra-ocular pressure (mmHg)14.4 (±2.8)15.9 (±2.0)15.6 (±2.2)
Spherical equivalent0.28 (±1.86)−0.02 (±1.41)0.05 (±0.13)
MMSE (median, IQR)29.0 (29.0–30.0)29.0 (28.0–30.0)24.0 (20.0–26.0)
Hypertension N (%)75 (41.0%)23 (40.4%)16 (59.3%)
Diabetes mellitus N (%)8 (4.4%)3 (5.3%)2 (7.4%)
Coronary disease N (%)18 (9.8%)14 (24.6%)7 (25.9%)
  1. Data are means from the groups combined unless otherwise specified
  2. CI Cognitively Impaired, N Number of participants, OCT ptical Coherence Tomography, SIVA Singapore I Vessel Assessment, BCVA Best Corrected Visual Acuity, MMSE Mini-Mental State Exam, IQR Inter-Quartile Range, CERAD Consortium to Establish a Registry for Alzheimer’s Disease. Coronary disease in this case means a history of myocardial infarction or angina pectoris
\